Jason Leider | HIV & Diabetes | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Jason Leider
Affiliation Physician Affiliate Group of New York
Country United States
Scopus ID 55193803000
Documents 36
Citations 953
h-index 19
Subject Area HIV & Diabetes
Event Global Genetics Awards

Jason Leider
Physician Affiliate Group of New York

Jason Leider is a physician-scientist whose published research has addressed HIV testing, linkage to care, HIV/HCV coinfection, and clinical and public-health questions involving people living with HIV. His documented research record includes collaborative studies conducted through academic and public-health settings, with publications appearing in peer-reviewed medical journals. [2] [3]

Abstract

Jason Leider’s research record reflects sustained involvement in HIV medicine and related clinical and public-health research. Available publications document work on HIV testing in emergency-department environments, strategies for connecting HIV-positive individuals with specialized care, HIV/HCV coinfection, and barriers affecting HIV treatment and care. [2] [3] [4] His collaborative publications illustrate an applied research orientation in which clinical investigation is connected with patient engagement, healthcare access, testing strategies, and population health. [5]

Keywords

  • Jason Leider
  • Innovative Research Award
  • HIV research
  • HIV testing
  • HIV linkage to care
  • HIV/HCV coinfection
  • Clinical research
  • Public-health research
  • Emergency-department testing

Introduction

Research on HIV has increasingly incorporated clinical medicine, epidemiology, health services research, and implementation-oriented approaches. Within this broader field, HIV testing and linkage to appropriate care are important components of effective clinical and public-health systems. Leider has contributed to this area through studies examining testing practices and the transition of patients from diagnosis toward specialized HIV care. [2] [5]

Published work involving Leider also demonstrates attention to the intersection of HIV with other infectious and chronic health conditions. Research on HIV/HCV coinfection has considered clinical-management challenges and patient experiences, while later collaborative work has examined HIV diagnosis and clinical outcomes in the context of the COVID-19 pandemic. [4] [6] This multidisciplinary orientation provides a relevant foundation for recognition within an award category focused on innovative research.

Research Profile

The supplied research profile identifies HIV and diabetes as the principal subject area. The available bibliographic record, however, more directly documents Leider’s research activity in HIV medicine, HIV testing, linkage to care, HIV/HCV coinfection, and related clinical research. Accordingly, the profile is best interpreted as an interdisciplinary clinical-research portfolio rather than as a claim that every publication specifically addresses diabetes.

The supplied Scopus metrics comprise 36 documents, 953 citations, and an h-index of 19. [1] These indicators provide quantitative context for the visibility of the research record, while individual publications provide qualitative evidence of the problems addressed and the clinical settings in which the work has been conducted.

Research Contributions

Several themes characterize the documented research contributions associated with Jason Leider:

  • HIV testing: Research has examined operational and patient-oriented approaches to HIV testing in emergency-department settings, including the use of structured approaches to increase access to testing.
  • Linkage to HIV care: Leider has contributed to research evaluating methods for connecting individuals with positive HIV tests to specialized medical services after diagnosis. [2]
  • HIV/HCV coinfection: Collaborative research has investigated healthcare challenges affecting patients with HIV and hepatitis C virus coinfection, including clinical and psychosocial dimensions. [4]
  • Integrated infectious-disease testing: Leider participated in a randomized controlled trial examining bundled HIV and HCV testing in emergency-department care. [3]
  • Contemporary clinical research: His later collaborative work included investigation of HIV diagnosis and clinical outcomes among patients seeking care during the initial COVID-19 pandemic period in New York City’s public hospital system. [6]

Publications

The following selected publications illustrate the research themes documented in publicly accessible scholarly records. The list is representative rather than exhaustive and should not be interpreted as a complete bibliography.

  1. Leider, J., Fettig, J., & Calderon, Y. Engaging HIV-positive individuals in specialized care from an urban emergency department. AIDS Patient Care and STDs, 25(2), 89–93.
  2. Cowan, E., Herman, H. S., Rahman, S., Zahn, J., Leider, J., & Calderon, Y. Bundled HIV and Hepatitis C Testing in the Emergency Department: A Randomized Controlled Trial. Western Journal of Emergency Medicine, 19(6), 1049–1056.
  3. Lekas, H.-M., Siegel, K., & Leider, J. Challenges facing providers caring for HIV/HCV-coinfected patients. Qualitative Health Research, 22(1), 54–66.
  4. Kaplan-Lewis, E., Banga, J., Khan, M., et al., including Leider, J. HIV Diagnosis and the Clinical Course of COVID-19 Among Patients Seeking Care Within the New York City Public Hospital System During the Initial Pandemic Peak. AIDS Patient Care and STDs, 35(12). [6]
  5. Mohammed, D. Y., Brewer, R., Leider, J., Martin, E., & Choe, S. Barriers to HIV rapid start among New Jersey providers. HIV Research & Clinical Practice, 25(1), 2402140.

Research Impact

The supplied bibliometric profile reports 953 citations and an h-index of 19, indicating measurable scholarly uptake of the research record. [1] Beyond citation metrics, the documented publications address practical questions concerning HIV testing, linkage to specialized care, integrated infectious-disease testing, and healthcare delivery. Such research can contribute to clinical and public-health discussions by examining how evidence-based testing and care pathways operate in real-world healthcare settings.

The research portfolio also demonstrates collaboration across medical, epidemiological, and public-health disciplines. Studies involving emergency departments, HIV services, and public hospital systems illustrate an applied orientation toward questions that connect research findings with healthcare implementation. [2] [3] [6]

Award Suitability

For an Innovative Research Award, the documented record provides several relevant considerations. First, the research addresses clinically important HIV-related questions using observational, qualitative, prospective, and randomized study approaches. [2] [3] Second, the work emphasizes practical aspects of healthcare delivery, including testing and linkage to care. Third, the publication record demonstrates collaborative engagement across institutions and professional disciplines.

The award assessment should nevertheless distinguish documented evidence from promotional interpretation. Bibliometric indicators such as citations and h-index are useful measures of scholarly visibility but do not independently establish research quality or innovation. A complete award evaluation would therefore consider the originality of individual contributions, methodological rigor, significance of findings, reproducibility, leadership, and broader influence alongside bibliometric evidence.

Conclusion

Jason Leider’s documented research profile reflects sustained scholarly engagement with HIV medicine, testing, linkage to care, HIV/HCV coinfection, and related clinical and public-health questions. His publications demonstrate an applied research approach that connects clinical investigation with healthcare delivery and patient access. [2] [3] The supplied Scopus metrics of 36 documents, 953 citations, and an h-index of 19 provide additional bibliometric context. [1] On the evidence documented here, his interdisciplinary and clinically oriented research record is relevant to consideration for an Innovative Research Award, subject to the formal evaluation criteria of the awarding organization.

References

  1. Elsevier. (n.d.). Scopus author details: Jason Leider, Author ID 55193803000. Scopus. Bibliometric values supplied for this profile: 36 documents, 953 citations, and h-index 19.
    https://www.scopus.com/authid/detail.uri?authorId=55193803000
  2. Leider, J., Fettig, J., & Calderon, Y. (2011). Engaging HIV-positive individuals in specialized care from an urban emergency department. AIDS Patient Care and STDs, 25(2), 89–93. DOI: https://doi.org/10.1089/apc.2010.0205
  3. Cowan, E., Herman, H. S., Rahman, S., Zahn, J., Leider, J., & Calderon, Y. (2018). Bundled HIV and Hepatitis C Testing in the Emergency Department: A Randomized Controlled Trial. Western Journal of Emergency Medicine, 19(6), 1049–1056. DOI: https://doi.org/10.5811/westjem.2018.8.37827
  4. Lekas, H.-M., Siegel, K., & Leider, J. (2012). Challenges facing providers caring for HIV/HCV-coinfected patients. Qualitative Health Research, 22(1), 54–66. DOI: https://doi.org/10.1177/1049732311418248
  5. Bauman, L. J., Braunstein, S., Calderon, Y., Chhabra, R., Cutler, B., Leider, J., Rivera, A., Sclafane, J., Tsoi, B., & Watnick, D. (2013). Barriers and facilitators of linkage to HIV primary care in New York City. Journal of Acquired Immune Deficiency Syndromes, 64(Suppl. 1), S20–S26. DOI: https://doi.org/10.1097/QAI.0b013e3182a99c19
  6. Kaplan-Lewis, E., Banga, J., Khan, M., Casey, E., Mazumdar, M., Bratu, S., Abdallah, M., Pitts, R., Leider, J., Hennessey, K., Cohen, G. M., Cleland, C. M., & Salama, C. (2021). HIV Diagnosis and the Clinical Course of COVID-19 Among Patients Seeking Care Within the New York City Public Hospital System During the Initial Pandemic Peak. AIDS Patient Care and STDs, 35(12). DOI: https://doi.org/10.1089/apc.2021.0124

Laila Darwich Soliva | WGS AMR transmission| Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Laila Darwich Soliva
Affiliation Universitat Autònoma de Barcelona
Country Spain
Scopus ID 8514531300
Documents 101
Citations 3,917
h-index 37
Subject Area WGS AMR transmission
Event Global Genetics Awards
ORCID 0000-0001-9027-9452

Laila Darwich Soliva
 Universitat Autònoma de Barcelona

Laila Darwich Soliva is a researcher and academic at the Universitat Autònoma de Barcelona (UAB), Spain, working in animal health, infectious diseases, antimicrobial resistance and One Health research. Her institutional research profile identifies her within the Department of Animal Health and Anatomy and the research group TRANSMISAN. The profile records a substantial body of peer-reviewed research and an h-index of 37. [1]

Abstract

The Innovative Research Award profile recognizes the research activities of Laila Darwich Soliva in the fields of animal health, infectious diseases, antimicrobial resistance and One Health. Her academic work is associated with the Universitat Autònoma de Barcelona, where she is affiliated with the Department of Animal Health and Anatomy and the TRANSMISAN research group. Institutional records describe research outputs addressing bacterial pathogens, antimicrobial-resistance determinants, zoonotic disease and genomic surveillance. [1]

Her research trajectory combines veterinary science with microbiological, epidemiological and genomic approaches. This interdisciplinary orientation is particularly relevant to contemporary surveillance of antimicrobial resistance, where understanding transmission across animal, environmental and human populations requires integrated One Health methodologies. Her publication record and citation indicators provide quantitative evidence of sustained scholarly activity. [1]

Keywords

Laila Darwich Soliva; Innovative Research Award; Universitat Autònoma de Barcelona; antimicrobial resistance; whole-genome sequencing; WGS; AMR transmission; infectious diseases; veterinary medicine; One Health; zoonoses; bacterial genomics; antimicrobial-resistance genes; genomic surveillance; animal health.

Introduction

Darwich Soliva’s research profile is situated within this interdisciplinary environment. UAB records identify her academic activities with the Department of Animal Health and Anatomy and the TRANSMISAN group, while her institutional profile documents research outputs spanning animal infectious diseases, antimicrobial resistance and related One Health topics. [1]

Her academic career also includes formal training in veterinary medicine and postgraduate research experience. The UAB research portal records a PhD in Veterinary Medicine awarded in 2004 and previous postdoctoral research activity at the Germans Trias i Pujol Health Sciences Research Institute. [1]

Research Profile

The research profile of Laila Darwich Soliva reflects an interdisciplinary approach to infectious diseases and animal health. Her institutional affiliation places her within the scientific area of Animal Health, with research activities connected to transmissible diseases and One Health. [1]

  • Veterinary medicine and animal health research.
  • Antimicrobial resistance and antimicrobial-resistance determinants.
  • Whole-genome sequencing and bacterial genomic characterization.
  • Zoonoses and infectious diseases at the animal–human interface.
  • One Health approaches to infectious-disease surveillance.
  • Epidemiological investigation of pathogens in animal and wildlife populations.

The UAB research portal currently lists more than one hundred research outputs associated with her profile, including articles, reviews, book chapters and other scholarly contributions. Recent examples include research on antimicrobial-resistance genes in wildlife and livestock-associated bacteria and genomic characterization of Klebsiella strains. [1]

Research Contributions

A central contribution of Darwich Soliva’s research is the application of genomic and microbiological methods to questions of antimicrobial resistance and infectious-disease transmission. Research listed by UAB includes work examining the global distribution of antimicrobial-resistance genes in Escherichia coli isolated from wild animals, as well as studies of antibiotic determinants and heavy-metal resistance genes in E. coli from pigs in Catalonia. [1]

Her recent research record also includes whole-genome characterization of Klebsiella strains identified in European hedgehogs and human nosocomial settings, with attention to shared sequence types, antimicrobial-resistance genes and plasmids. Such work illustrates the value of genomic comparison for understanding bacterial populations across ecological and clinical contexts. [1]

Additional research activities address antimicrobial resistance in companion-animal and wildlife contexts, including studies of canine otitis pathogens and resistant bacterial populations. These research directions contribute to a broader evidence base for antimicrobial stewardship and surveillance within veterinary and One Health frameworks. [1]

Publications

The institutional research portal lists a substantial publication record for Laila Darwich Soliva. Examples of recent research outputs include peer-reviewed studies addressing antimicrobial resistance, bacterial genomics and wildlife-associated pathogens. [1]

  • Detection of Extended-Spectrum β-Lactamase–Producing Bacteria and CMY-2 Genes in Coypu (Myocastor coypus) in Catalan Wetlands, Northeast Spain, published in the Journal of Wildlife Diseases in 2026. [1]
  • Whole Genome Characterization of Klebsiella Strains in European Hedgehogs and Human Nosocomial Settings Identified Shared Sequence Types, Antimicrobial Resistance Genes and Plasmids, published in Zoonoses and Public Health in 2026. [1]
  • Characterization of antibiotic determinants and heavy metal resistance genes in Escherichia coli from pigs in Catalonia, published in Microbial Genomics in 2025. [1]
  • Global distribution of antimicrobial resistance genes in Escherichia coli isolated from wild animals using genomes available in public databases, published in Science of the Total Environment in 2025. [1]
  • Trends in Antimicrobial Resistance of Canine Otitis Pathogens in the Iberian Peninsula (2010–2021), published in Antibiotics in 2025. [1]

Publication-specific DOI information should be verified against the publisher or DOI registry before being used as a bibliographic identifier. No DOI is asserted here where the supplied researcher profile does not provide a verified DOI value.

Research Impact

The supplied research metrics identify 101 documents, approximately 3,917 citations and an h-index of 37. The UAB research portal independently reports an h-index of 37 and a citation count displayed at approximately 3,931 at the time of its indexed profile, illustrating that citation totals can vary according to database update timing and indexing coverage. [1]

Beyond bibliometric indicators, the research profile has relevance to infectious-disease surveillance, veterinary public health and antimicrobial-resistance monitoring. Studies involving wildlife, livestock, companion animals and bacterial genomic data demonstrate the potential value of integrated surveillance approaches for identifying resistance determinants and understanding pathogen circulation across populations. [1]

Her academic activities also extend into postgraduate and multidisciplinary education. The UAB Master’s Degree in Zoonoses and One Health identifies Laila Darwich Soliva as coordinator and teaching staff member, reflecting an educational role connected with multidisciplinary approaches to zoonotic disease and One Health. [2]

Award Suitability

The research record provides a substantive basis for consideration under an Innovative Research Award framework. Relevant factors include sustained scholarly output, a documented research focus on infectious diseases and antimicrobial resistance, application of genomic approaches to bacterial surveillance, and participation in multidisciplinary One Health education and research. [1] [2]

  • Research relevance: Her work addresses antimicrobial resistance, infectious diseases and animal health, areas of continuing scientific and public-health importance.
  • Methodological scope: Her research includes genomic characterization and whole-genome sequencing approaches relevant to bacterial surveillance.
  • Interdisciplinary contribution: The research connects veterinary medicine, microbiology, epidemiology, genomics and One Health.
  • Scholarly record: The institutional profile documents a substantial body of research output and established citation impact. [1]
  • Educational contribution: Her involvement in the UAB Zoonoses and One Health master’s programme demonstrates engagement with multidisciplinary scientific education. [2]

Award suitability remains subject to the formal evaluation criteria, documentation requirements and independent review procedures established by the Genetics Awards programme. The information presented here should therefore be regarded as an academic recognition profile rather than a determination of award outcome.

Conclusion

Laila Darwich Soliva’s academic profile represents sustained research activity in animal health, infectious diseases, antimicrobial resistance and One Health. Her work incorporates genomic and epidemiological perspectives that are increasingly important for understanding antimicrobial-resistance patterns and pathogen transmission across animal and human environments. [1]

The combination of research productivity, citation impact, interdisciplinary investigation and academic engagement provides a strong scholarly context for consideration for an Innovative Research Award. Her institutional record further demonstrates involvement in postgraduate education and multidisciplinary One Health training. [1] [2]

References

  1. Universitat Autònoma de Barcelona. (n.d.). Laila Darwich Soliva — Research Portal. Department of Animal Health and Anatomy; Grup de Recerca en Malalties Transmissibles en Sanitat Animal (TRANSMISAN).

    https://portalrecerca.uab.cat/en/persons/laila-darwich-soliva-7/

  2. Evolution and Antimicrobial Resistance Profiles of Klebsiella spp. Infections in Companion Animals in the Iberian Peninsula

    https://www.mdpi.com/2079-6382/15/7/678

  3. Detection of Extended-Spectrum β-Lactamase–Producing Bacteria and CMY-2 Genes in Coypu (Myocastor coypus) in Catalan Wetlands, Northeast Spain
    https://pubmed.ncbi.nlm.nih.gov/41698668/

  4. Elsevier. (n.d.). Scopus author details: Laila Darwich Soliva, Author ID 8514531300.

    Scopus.https://www.scopus.com/pages/authors/8514531300

Safaa Abdel-Karim | Genetic Variation and its impact | Editorial Board Member 

Published on by Global Genetics Award

Dr. Safaa Abdel-Karim | Genetic Variation and its impact | Editorial Board Member 

Zagazig University | Egypt

Author Profile

Google Scholar

EARLY ACADEMIC PURSUITS:

Dr. Safaa Abdel-Karim embarked on her academic journey with a focus on microbiology and immunology. Her formative years were marked by a passion for understanding the intricacies of these fields, laying the foundation for a promising career.

PROFESSIONAL ENDEAVORS:

Upon joining the Department of Microbiology and Immunology at Zagazig University's Faculty of Pharmacy, Dr. Abdel-Karim dedicated herself to advancing her expertise. She actively engaged in teaching, research, and administrative responsibilities, showcasing a commitment to both academic and professional growth.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENETIC VARIATION AND ITS IMPACT:

Dr. Abdel-Karim's contributions to microbiology and immunology have been substantial. Through pioneering research endeavors, she has addressed critical questions, expanded scientific knowledge, and contributed to advancements in these disciplines. Her work reflects a dedication to pushing the boundaries of understanding within her field.

IMPACT AND INFLUENCE:

The impact of Dr. Abdel-Karim's research extends beyond the confines of academia. Her influential work has garnered recognition within the scientific community and has the potential to shape the future trajectory of microbiology and immunology. Her findings may hold practical implications for various applications, including healthcare and biotechnology.

ACADEMIC CITES:

Dr. Abdel-Karim's research output is not only profound but has also received noteworthy citation in academic circles. The frequency and depth of citations reflect the significance of her contributions and the resonance they have within the scholarly community.

LEGACY:

A legacy is built not only on accomplishments but also on the students and colleagues influenced. Dr. Abdel-Karim's legacy is evident in the minds she has shaped and the collaborative spirit she has fostered. Her impact reverberates through the academic corridors, leaving an indelible mark on future generations of scholars.

FUTURE CONTRIBUTIONS:

Looking forward, Dr. Abdel-Karim continues to chart a course of significance. Her future contributions hold the promise of further enriching the fields of microbiology and immunology, with potential breakthroughs that may reverberate across disciplines.

Notable Publications:

Promising FDA-approved drugs with efflux pump inhibitory activities against clinical isolates of Staphylococcus aureus 2022(10)

Antibiotic resistance of Enterococcus faecalis and Enterococcus faecium isolated from urinary tract infections in Zagazig University hospitals 2021(1)